JTCC brings leading experts to present 2011 San Antonio Breast Cancer Symposium research

January 26th, 2012

(January 26, 2012) – Mark your calendars, the Breast Cancer Division of the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will recap and explain research from the 2011 San Antonio Breast Cancer Symposium on Friday, February 17 from 7:00 am to 3:00 pm during its ninth annual Northern New Jersey Breast Cancer Conference.

The San Antonio Breast Cancer Symposium is recognized internationally as one of the most important research conferences for breast cancer. This year's event focused on emerging treatments in hard-to-treat populations, including patients with metastatic breast cancer, and on new knowledge about prevention and risk.

"We are constantly searching for the latest treatments and therapies to help our patients beat cancer, " said Stanley Waintraub, M.D., Co-Chief, Breast Oncology, John Theurer Cancer Center. "Part of that includes understanding the most recent developments in clinical oncology. We are excited to share and explain what this year's San Antonio conference means for health care professionals and patients."

The objective of the ninth annual Northern New Jersey Breast Cancer Conference is to provide the New Jersey medical community with practical information on experimental biology, etiology, prevention, diagnosis and therapy of breast cancer/premalignant breast disease. Physicians and researchers involved in medical surgery, GYN and radiation therapy, as well as other appropriate health care professionals are encouraged to attend.

Attendees will learn about new therapies available in breast cancer, patients who will benefit from the new treatments in advanced/metastatic disease, and new combination therapies for metastatic disease. The agenda includes renowned speakers from some of the best cancer centers in the country, including:

• Mary Elizabeth Cianfrocca, D.O., Director, Breast Cancer Program, Banner M.D. Anderson Cancer Center
• Edith A. Perez, M.D., Director, Breast Cancer Program, Mayo Clinic
• Freya R. Schnabel, M.D., Professor of Surgery, NYU School of Medicine
• Howard A. Burris, M.D., Chief Medical Officer, Sarah Cannon Research Institute
• Lawrence J. Solin, M.D., F.A.C.R., Chairman, Radiation Oncology, Albert Einstein Medical Center

"Extraordinary care means providing the very best and latest in research and innovation, ensuring for our patients that they will receive cutting edge, world-class cancer care," said Andrew L Pecora, M.D., F.A.C.P., C.P.E, Chief Innovations Officer, Professor, and Vice President of Cancer Services. "We are pleased to be hosting the ninth annual Northern New Jersey Breast Cancer Conference in 2012."

Provided by John Theurer Cancer Center